In Re: Rivastigmine Patent Litigation

NPE Status
Practicing Entity
Declaratory Judgment
No
Civil Action
1:05-md-01661
Filing Date
Venue
S.D.N.Y.
Termination Date
US Patent No
4948807
5602176

Patent Asserters:

Patent Asserter
Novartis Pharma AG
8 Product company
Novartis AG
8 Product company
Novartis International Pharmaceutical Ltd.
8 Product company
Novartis Pharmaceuticals Corporation
8 Product company
Proterra AG
13 Corporate-inventor-started company

Alleged Infringers:

Sun Pharmaceutical Industries Ltd.
Watson Pharmaceuticals, Inc
Ranbaxy Pharmaceuticals, Inc.
Ranbaxy Inc.
Watson Laboratories, Inc.
Ranbaxy Laboratories Limited
Dr. Reddy's Laboratories, Ltd.
Dr. Reddy's Laboratories, Inc.